A survey of therapeutic drug monitoring in Australasia

Norris, Ross, Morris, Ray, Thompson, Erin, Ray, John, Barras, Michael, Jones, Graham and Martin, Jenny (2009). A survey of therapeutic drug monitoring in Australasia. In: , Therapeutic Drug Monitoring: Abstracts of: 11th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology. 11th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, Montréal, QC, Canada, (664-665). 3-8 October 2009.


Author Norris, Ross
Morris, Ray
Thompson, Erin
Ray, John
Barras, Michael
Jones, Graham
Martin, Jenny
Title of paper A survey of therapeutic drug monitoring in Australasia
Conference Paper Type Fully Published Paper
Conference name 11th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology
DOI 10.1097/FTD.0b013e3181b7997b
Conference location Montréal, QC, Canada
Conference dates 3-8 October 2009
Proceedings title Therapeutic Drug Monitoring: Abstracts of: 11th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology  (ERA 2012 Listed)    (ERA 2010 Rank B)   Check publisher's open access policy
Journal name Therapeutic Drug Monitoring  (ERA 2012 Listed)    (ERA 2010 Rank B)   Check publisher's open access policy
Place published New York, NY, U.S.A.
Publisher Lippincott-Raven
Publication date 2009
Volume number 31
Issue number 5
ISSN 0163-4356; 1536-3694
Start page 664
End page 665
Total pages 2
Collection year 2010
Language eng
Formatted Abstract/Summary Methods: A survey of therapeutic drug monitoring (TDM) practices in Australasia was undertaken in late 2007 with 57 responses received. 42% described the responding institution as a hospital, 11% as a hospital pathology provider and 47% as pathology provider. Areas surveyed included assays provided, dosing regimen advice and monitoring advice.

Conclusion: The provision of high quality TDM services requires more than issuing drug assay results. The survey has highlighted the need to define the appropriate level of practice in this area. These data also suggest the need to strengthen post-analytical support for current TDM services. Funding may be a major issue and further pharmacoeconomic studies may be necessary to support the case for funding improvements. A multi-disciplinary web-based group has been established in Australasia to support all aspects of TDM.
© 2009 Lippincott Williams & Wilkins
Subjects E4
111502 Clinical Pharmacology and Therapeutics
920299 Health and Support Services not elsewhere classified
Q-Index Code E4
Q-Index Status Provisional Code
Institutional Status UQ
Additional Notes Presented as Poster P328. Published October 2005, under "Miscellaneous Including Hepotoxicity".

Document type: Conference Paper
Sub-type: Fully Published Paper
Collection: School of Pharmacy Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 0 times in Thomson Reuters Web of Science Article
Google Scholar Search Google Scholar
Access Statistics: 49 Abstract Views  -  Detailed Statistics
Created: Mon, 25 Jan 2010, 12:29:51 EST by Charna Kovacevic on behalf of School of Pharmacy